Prevalence of Asthma and Allergic Rhinitis Among Adults in Yaounde, Cameroon
Overview
Authors
Affiliations
Background: Population-based estimates of asthma and allergic rhinitis in sub-Saharan African adults are lacking. We assessed the prevalence and determinants of asthma and allergic rhinitis in urban adult Cameroonians.
Methods: A community-based survey was conducted from December 2013 to April 2014 among adults aged 19 years and above (N = 2,304, 57.3% women), selected through multilevel stratified random sampling across all districts of Yaounde (Capital city). Internationally validated questionnaires were used to investigate the presence of allergic diseases. Logistic regressions were employed to investigate the determinants of allergic conditions.
Results: Prevalence rates were 2.7% (95% CI: 2.1-3.4) for asthma-ever, 6.9% (5.9-7.9) for lifetime wheezing, 2.9% (92.2-3.6) for current wheezing and 11.4% (10.1-12.7) for self-reported lifetime allergic rhinitis; while 240 (10.4%) participants reported current symptoms of allergic rhinitis, and 125 (5.4%) had allergic rhino-conjunctivitis. The prevalence of current asthma medication use and self-reported asthma attack was 0.8 (0.4-1.2) and 1 (0.6-1.4) respectively. Multivariable adjusted determinants of current wheezing were signs of atopic eczema [2.91 (1.09-7.74)] and signs of allergic rhinitis [3.24 (1.83-5.71)]. Age group 31-40 years [0.27(0.09-0.78), p = 0.016] was an independent protective factor for wheezing. Determinants of current rhinitis symptoms were active smoking [2.20 (1.37-3.54), p<0.001], signs of atopic eczema [2.84 (1.48-5.46)] and current wheezing [3.02 (1.70-5.39)].
Conclusion: Prevalence rates for asthma and allergic rhinitis among adults in this population were at the lower tails of those reported in other regions of the world. Beside the classical interrelation between allergic diseases found in this study, active smoking was an independent determinant of allergic rhinitis symptoms. Nationwide surveys are needed to investigate regional variations.
Jain S Indian J Otolaryngol Head Neck Surg. 2024; 76(6):5746-5749.
PMID: 39559030 PMC: 11569326. DOI: 10.1007/s12070-024-05084-x.
The role of matrix metalloproteinase-2 and miR-196a2 in bronchial asthma pathogenesis and diagnosis.
Mohammed O, Doghish A, Alamri M, Alharthi M, Alfaifi J, Adam M Heliyon. 2024; 10(6):e27694.
PMID: 38509956 PMC: 10950666. DOI: 10.1016/j.heliyon.2024.e27694.
Arrais M, Maricoto T, Lulua O, Quifica F, M R Gama J, Brito M Afr Health Sci. 2024; 23(3):672-682.
PMID: 38357136 PMC: 10862642. DOI: 10.4314/ahs.v23i3.78.
MCP-1-2518 (A>G) polymorphism and asthma risk: a pilot case-control study in Cameroon.
Nkeck J, Nkeck J, Chedjou J, Ndoadoumgue A, Essama D, Afane Ze E Pan Afr Med J. 2023; 44:166.
PMID: 37455894 PMC: 10349619. DOI: 10.11604/pamj.2023.44.166.38544.
[Role of sugarcane pollen in allergic rhinitis: a case-control study].
Randrianandraina P, Solo C, Andriambelo R, Razafimahatratra M, Ramilison H, Mamiharilala M Pan Afr Med J. 2022; 41:133.
PMID: 35519171 PMC: 9034559. DOI: 10.11604/pamj.2022.41.133.27897.